Your browser doesn't support javascript.
loading
Antioxidant treatment in peripheral artery disease: the rationale is there, but what about clinical results?
Giannopoulos, Georgios; Angelidis, Christos; Vogiatzi, Georgia; Cleman, Michael W; Deftereos, Spyridon.
Affiliation
  • Giannopoulos G; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA. Electronic address: georgios.giannopolous@yale.edu.
  • Angelidis C; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Vogiatzi G; 1st Department of Cardiology, University of Athens Medical School, Hippokration Hospital, Athens, Greece.
  • Cleman MW; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Deftereos S; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA; 1st Department of Cardiology, University of Athens Medical School, Hippokration Hospital, Athens, Greece.
Curr Opin Pharmacol ; 39: 53-59, 2018 04.
Article in En | MEDLINE | ID: mdl-29486422
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Arterial Disease / Antioxidants Limits: Humans Language: En Journal: Curr Opin Pharmacol Journal subject: FARMACOLOGIA Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Arterial Disease / Antioxidants Limits: Humans Language: En Journal: Curr Opin Pharmacol Journal subject: FARMACOLOGIA Year: 2018 Type: Article